BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

$1.73
+0.09 (+5.49%)
As of Apr 1, 3:26 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,443.4% upside
Low Target $29.80
Average Target $44.00
High Target $55.04
Current Price $1.73
Current
$1.73
Target
$44.00
$29.80 $44.00 avg $55.04
Scenario Analysis
Bear Case
$29.80
1,622.5%
Low target
Base Case
$44.00
+2,443.4%
Avg target
Bull Case
$55.04
+3,081.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.44
-49.7% from high
52-Week Low
$0.98
+76.5% from low
Target vs 52W High
$44.00
+1,179.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%